跳至主要内容
临床试验/NCT02185170
NCT02185170终止不适用

Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections.

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2014年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
5
试验地点
1
主要终点
Complete fluorescence measurement over each field of vision.

研究概览

简要总结

The aim of this study is divided in 4 different steps:

  • the first step has two different purpose: assess the impact of the storage medium of fresh prostatic chips on fluorescence signal and adjust the entire chain (immunolabelling,counter-stain and imaging),
  • the second step is the adaptation of immunolabelling protocol on histopathology slides, using fresh prostatic tissue,
  • the third step is to validate the use of:
  1. the medical device created by the FEMTO-ST institute use for the detection of fluorescence signal on fresh tissue,
  2. the Light-CT scanner use for tissue structural observation.
  • the four step is to check the preservation of morphological structure of tissue under the effect of laser excitation from the medical device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Male patient over 18 years old.
  • •Patient scheduled for trans-urethral resection of prostate with:
  • •prostate specific antigen (PSA) blood level ≤ 4 ng/ml and age > 80 years old
  • •a suspected prostate cancer after a digital rectal examination (DRE) and a PSA blood level > 50 ng/ml or an existing prostate cancer
  • •Patient affiliated to social security or beneficiary of such a regime.

排除标准

  • •Protected patient referred to in Articles L1121-6 to L1121-8 of the Code of Public Health

研究组 & 干预措施

Fluorescence assesment

Experimental

All patients undergo a transurethral resection.

There are four different steps in the study:

  • the first step: fresh prostatic tissue of 30 subjects will be use to asses the fluorescence signal and the entire chain,
  • the second step: fresh prostatic tissue of 10 subjects will be used to asses the immunolabelling protocol,
  • the third step: fresh prostatic tissue of 20 subjects will be used to asses the use of the FEMTO-ST institute medical device,
  • the four step: the fresh prostatic tissue from the 10 subjects of the second step will be evaluated to verify the preservation of morphological structure with the use of the Light-CT scanner.

干预措施: Trans-urethral resection (Procedure)

Fluorescence assesment

Experimental

All patients undergo a transurethral resection.

There are four different steps in the study:

  • the first step: fresh prostatic tissue of 30 subjects will be use to asses the fluorescence signal and the entire chain,
  • the second step: fresh prostatic tissue of 10 subjects will be used to asses the immunolabelling protocol,
  • the third step: fresh prostatic tissue of 20 subjects will be used to asses the use of the FEMTO-ST institute medical device,
  • the four step: the fresh prostatic tissue from the 10 subjects of the second step will be evaluated to verify the preservation of morphological structure with the use of the Light-CT scanner.

干预措施: Use of the FEMTO-ST institute medical device (Device)

Fluorescence assesment

Experimental

All patients undergo a transurethral resection.

There are four different steps in the study:

  • the first step: fresh prostatic tissue of 30 subjects will be use to asses the fluorescence signal and the entire chain,
  • the second step: fresh prostatic tissue of 10 subjects will be used to asses the immunolabelling protocol,
  • the third step: fresh prostatic tissue of 20 subjects will be used to asses the use of the FEMTO-ST institute medical device,
  • the four step: the fresh prostatic tissue from the 10 subjects of the second step will be evaluated to verify the preservation of morphological structure with the use of the Light-CT scanner.

干预措施: Use of the Light-CT scanner (Device)

结局指标

主要结局

Complete fluorescence measurement over each field of vision.

时间窗: 1 day

Determinate for the anti-PSMA antibody with Alexa Fluor 488 tracer, the ideal couple of antibody concentration/incubation time giving the highest immunofluorescent signal in the adjustment of fixed tissue sample protocol to fresh tissue sample protocol.

次要结局

  • Complete fluorescence measurement over each field of vision.(1 day)
  • Comparison of prostatic chips tissue architecture between the images from the Light-CT scanner and standard histopathology slides(1 day)
  • Quality criteria of the structure of tissue (ordinal qualitative variables).(1 day)
  • Fluorescence measurements mean.(1 day)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

DEPORRA-CoProst: Assessment of New Fluorescence... | 临床试验